Alligator Bioscience
5.516
SEK
-5.71 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-5.71%
-32.73%
-71.63%
-73.8%
-94.74%
-93.82%
-94.61%
-98.17%
-99.68%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
93.25M SEK
Turnover
599.07K SEK
Revenue
57.77M
EBIT %
-396.64 %
P/E
-
Dividend yield-%
-
Financial calendar
24.4
2025
Interim report Q1'25
5.7
2025
General meeting '25
10.7
2025
Interim report Q2'25
All
Webcasts
Press releases
ShowingAll content types
Alligator Bioscience determines record date for reverse share split of ordinary shares and reminds of the recalculation of warrants
Change in number of shares and votes in Alligator Bioscience AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools